Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Herb Greenberg lays out the risks in Apple, Decker and Hims & Hers
02:58pm, Monday, 10'th Feb 2025
Herb Greenberg, Herb Greenberg on the Street editor, joins 'Power Lunch' to discuss Apple's troubles in China, Deckers headwinds ahead and Hims and Hers core business slump.
Hims & Hers Super Bowl ad sparks controversy over weight loss drug sourcing
02:30pm, Monday, 10'th Feb 2025
CNBC's Brandon Gomez breaks down the controversy around the Hims & Hers Super Bowl ad.
Hims & Hers Super Bowl ad draws scrutiny from lawmakers
01:30pm, Monday, 10'th Feb 2025
Hims & Hers Health (HIMS) stock moves a notch higher Monday morning after the company's weight-loss drug ad played during the Super Bowl. The commercial's airing raised concerns from health experts an
Hims & Hers Super Bowl ad sparks controversy
12:04pm, Monday, 10'th Feb 2025
CNBC's Brandon Gomez joins 'Squawk on the Street' to break down the controversy around Hims & Hers Super Bowl ads.
Hims & Hers Health: Meme Potential Could Propel Explosive Growth
09:53am, Monday, 10'th Feb 2025
Hims has a great deal of meme potential, which could benefit the company by effectively acting as free advertising. Putting aside Hims meme potential, the company is still in a great position to disru
Hims & Hers stock price target according to the C&H pattern
04:02am, Monday, 10'th Feb 2025
Hims & Hers stock price continues to fire on all cylinders this year and is hovering near its highest level on record. It has soared by almost 1,500% from its lowest level in 2023, transforming it int
Hims & Hers faces backlash over ‘misleading' Super Bowl ad—but it didn't stop stock from jumping over 11%
06:40am, Sunday, 09'th Feb 2025
Telehealth company Hims & Hers Health is fighting back after the drug industry's main lobbying group called out its first Super Bowl ad as “misleading” and in potential violation of marketing rule
Global Healthy Living Foundation Says Hims & Hers Health Super Bowl Ad Omits Risks of Weight Loss Drug
02:00pm, Saturday, 08'th Feb 2025
UPPER NYACK, N.Y.--(BUSINESS WIRE)--Global Healthy Living Foundation Says Hims & Hers Health Super Bowl ad omits safety risks and side effects of its weight loss drug.
Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad
03:29pm, Friday, 07'th Feb 2025
Hims & Hers is under fire over an ad for its weight loss offerings that's slated to run during the Super Bowl on Sunday. Two U.S. senators expressed concern over an "upcoming advertisement" that "risk
Why Hims & Hers Health (HIMS), Tempus AI (TEM) and Teladoc (TDOC) Are Up Big Today
12:53pm, Friday, 07'th Feb 2025
Stock markets got a bit of a shock on Friday after a University of Michigan survey showed consumers are anticipating inflation to rise in 2025, potentially depressing consumer spending and dissuading
Hims & Hers Health, Inc. (HIMS) Exceeds Market Returns: Some Facts to Consider
06:51pm, Wednesday, 05'th Feb 2025
The latest trading day saw Hims & Hers Health, Inc. (HIMS) settling at $42.20, representing a +0.84% change from its previous close.
Trump Tariffs Threaten MedTech: 3 Stocks to Mitigate Risks
01:15pm, Wednesday, 05'th Feb 2025
Three companies that are better positioned to withstand Trump's tariff challenges are ResMed, Hims & Hers Health and Medtronic.
Hims & Hers Launches Health Collective and Community Member Council
09:00am, Tuesday, 04'th Feb 2025
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced two new programs dedicated to serving its customers
Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
04:05pm, Monday, 03'rd Feb 2025
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 202
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
10:01am, Monday, 03'rd Feb 2025
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
